sinc
plasmidbas
revers
genet
rg
system
revolution
way
influenza
virus
studi
howev
unusu
encount
clone
difficulti
one
influenza
gene
attempt
recov
viru
de
novo
overcom
shortcom
sought
develop
partial
full
plasmidfre
rg
system
influenza
gene
choic
assembl
rg
compet
unit
virtu
overlap
pcr
reaction
contain
cdna
copi
viral
gene
segment
control
rna
polymeras
promot
termin
signal
herein
refer
flu
pcr
amplicon
transfect
tissu
cultur
cell
either
ha
na
flu
pcr
amplicon
plasmid
encod
remain
influenza
rg
unit
result
effici
viru
rescu
likewis
transfect
includ
ha
na
flu
pcr
amplicon
rg
plasmid
also
result
effici
viru
rescu
addit
influenza
virus
recov
full
set
flu
pcr
amplicon
without
use
plasmid
type
influenza
flu
virus
belong
famili
orthomyxovirida
genom
consist
eight
segment
singl
strand
rna
neg
polar
viral
rna
vrna
found
virion
infect
cell
form
viral
ribonucleoprotein
particl
vrnp
associ
three
polymeras
subunit
pa
nucleoprotein
np
viru
encod
two
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
proton
pump
transmembran
protein
matrix
protein
nuclear
export
protein
nonstructur
protein
influenza
virus
altern
translat
start
site
segment
apoptosi
modulatori
protein
addit
viral
protein
product
includ
deriv
altern
start
site
within
orf
result
protein
product
lack
first
aa
pax
deriv
pa
mrna
consist
ntermin
aa
pa
fuse
aa
result
frameshift
de
novo
synthesi
influenza
virus
revers
genet
rg
requir
viral
rna
also
viral
protein
compon
thu
rg
system
influenza
reli
invari
dual
promot
concept
one
synthesi
vrna
segment
anoth
synthesi
viral
mrna
sinc
termini
influenza
vrna
crucial
viru
replic
plasmid
carri
rna
polymeras
rna
polymeras
promot
use
gener
vrna
exact
end
wherea
termin
sequenc
hepat
h
ribozym
use
gener
exact
end
plasmid
carri
typic
rna
polymeras
ii
promot
cmv
andor
chicken
bactin
promot
util
synthesi
influenza
mrna
despit
great
advantag
technolog
although
variat
plasmidbas
approach
develop
inevit
reli
clone
step
system
reli
clone
could
speed
studi
signific
mutat
viral
genom
replic
andor
modul
virul
report
flu
pcr
amplicon
instead
plasmid
effici
viabl
altern
plasmidbas
rg
system
flu
gfp
pcr
amplicon
deriv
order
determin
whether
flu
pcr
amplicon
could
transfect
cell
amplifi
influenza
polymeras
complex
pcr
product
produc
encod
gfp
report
gene
neg
orient
flank
influenza
segment
untransl
region
utr
flank
human
promot
mous
termin
signal
fig
fig
tabl
cotransfect
amplicon
along
protein
express
plasmid
encod
influenza
viru
polymeras
complex
np
cell
result
effici
amplif
report
replicon
detect
green
fluoresc
signal
fig
proport
green
cell
observ
compar
observ
posit
control
cell
cotransfect
np
express
plasmid
fig
fluoresc
signal
anoth
amplicon
lack
signal
present
fewer
cell
compar
amplicon
indic
run
transcript
rna
complex
may
result
vrna
fragment
incorrect
andor
incomplet
influenza
sequenc
fig
expect
fluoresc
signal
appear
cell
transfect
flu
gfp
pcr
amplicon
lack
element
utregfputr
fig
remov
plasmid
cotransfect
cell
either
pcr
amplicon
plasmid
fig
data
shown
initi
studi
expand
order
test
whether
pcr
amplicon
contain
rna
polymeras
ii
polyadenyl
sequenc
flank
appropri
orf
would
result
gene
express
fig
thu
pcr
amplicon
np
gene
obtain
use
set
primer
span
cytomegaloviru
promot
cmv
bovin
growth
hormon
bgh
polya
element
cotransfect
along
result
effici
report
replicon
express
indic
pcr
amplicon
either
transcript
element
appropri
transcrib
correspond
transcript
complex
fig
order
demonstr
whether
flu
pcr
amplicon
could
use
replac
plasmid
rg
system
strain
mouseadapt
achicken
north
herein
refer
respect
use
donor
ha
na
gene
fig
fig
specif
set
intern
primer
design
within
conserv
region
gene
segment
develop
order
maxim
gene
amplif
viral
cdna
prepar
assembl
appropri
ha
na
pcr
amplicon
fig
fig
b
pdm
pcr
amplicon
carri
fulllength
copi
ha
gene
strain
flank
signal
fig
respect
ha
gene
intern
primer
design
delet
polybas
amino
acid
signal
sequenc
rerrkrrr
replac
one
carri
monobas
cleavag
site
tetr
fig
fig
similar
strategi
follow
creat
na
amplicon
pdm
polna
viral
cdna
fig
fulllength
pdm
pdm
pcr
amplicon
obtain
confirm
sequenc
fig
addit
fulllength
ha
na
pcr
amplicon
gener
lack
either
sequenc
sequenc
serv
control
effici
viru
rescu
describ
sequenc
result
confirm
amplif
overlap
ha
amplicon
delet
polybas
cleavag
site
fulllength
amplif
polna
fig
fig
pcrbase
revers
genet
pcrbase
flu
report
replicon
encod
gfp
pcr
amplif
perform
use
primer
span
sequenc
agaros
gel
purif
test
show
pcr
product
devoid
plasmid
dna
contamin
flu
gfp
amplicon
transfect
cell
along
four
express
plasmid
encod
polymeras
complex
influenza
viru
express
gfp
reflect
influenza
polymeras
activ
vrna
flu
gfp
replicon
gener
transcript
flu
gfp
amplicon
variat
describ
main
text
shown
fig
b
start
influenza
viru
candid
vrna
cdna
reconstitut
fulllength
flu
pcr
amplicon
case
ha
na
pcr
amplicon
depict
perform
transfect
flu
pcr
amplicon
along
appropri
complementari
rg
plasmid
suscept
cell
lead
gener
recombin
influenza
virus
desir
gene
constel
strategi
speed
revers
genet
process
obviat
classic
clone
step
current
part
plasmidbas
rg
system
effici
influenza
viru
rescu
use
flu
pcr
amplicon
either
mode
pdm
ha
pcr
amplicon
tabl
cotransfect
cocultur
cell
mode
along
rg
plasmid
encod
correspond
addit
gene
segment
influenza
apuerto
rico
strain
h
h
posttransfect
hpt
cell
cotransfect
pdm
pcr
amplicon
plu
rg
plasmid
pdm
show
typic
virusinduc
cytopath
effect
cpe
pdm
viru
titer
hpt
reach
tcid
ml
time
lower
one
obtain
use
correspond
rg
plasmid
pdm
tcid
ml
tabl
subsequ
blind
passag
mdck
cell
dayold
embryon
chicken
egg
viru
titer
increas
tcid
ml
either
pdm
pcr
amplicon
whole
plasmidbas
rg
system
likewis
viru
could
rescu
use
ha
pcr
amplicon
rg
plasmid
tabl
hpt
viru
titer
transfect
cell
tcid
ml
increas
tcid
ml
passag
egg
tabl
hpt
ticd
titer
pcrbase
viru
time
less
viru
obtain
bidirect
plasmid
tabl
ident
reassort
confirm
sequenc
ha
gene
immunofluoresc
assay
ifa
fig
plaqu
assay
fig
expect
cpe
viru
detect
transfect
cell
rg
plasmid
plasmid
encod
ha
segment
omit
shown
plaqu
assay
viru
found
form
plaqu
agar
plate
presenc
absenc
mgml
tpck
fig
consist
reconstitut
monobas
cleavag
site
ha
gene
pcr
amplif
confirm
virus
carri
gene
andor
present
addit
mutat
introduc
pcr
amplif
virus
plaquepurifi
ha
gene
sequenc
analyz
plaquepurifi
virus
three
rg
virus
control
rgderiv
everi
singl
viru
isol
viru
group
contain
monobas
cleavag
site
ident
one
design
pcr
primer
mutat
identifi
elsewher
sequenc
analyz
viru
case
correspond
singl
nucleotid
chang
tabl
mutat
caus
amino
acid
chang
howev
chang
alter
antigen
make
virus
hi
assay
tabl
mutat
identifi
ha
sequenc
deriv
plaqu
obtain
rgderiv
virus
data
shown
result
highlight
high
fidel
pcr
approach
viru
fulli
laboratori
adapt
strain
recov
effici
rg
studi
perform
test
whether
pdm
pcr
amplicon
could
recov
background
rg
system
includ
aguinea
fowlhong
coldadapt
aann
strain
herein
refer
ca
respect
tabl
addit
viru
rescu
perform
context
background
tabl
regardless
rg
viru
background
use
viru
rescu
possibl
particularli
case
use
background
high
viru
titer
tcid
ml
initi
cotransfect
cell
obtain
either
pdm
ha
pcr
amplicon
pdm
respect
tabl
passag
egg
viru
titer
increas
significantli
fold
viru
viru
titer
limit
detect
observ
cell
cotransfect
context
rg
plasmid
ca
strain
carri
either
pdm
pdm
ca
ca
ha
pcr
amplicon
control
plasmid
pdm
ca
howev
fold
increas
viru
titer
observ
blind
passag
egg
supernat
ca
base
cotransfect
cell
reassort
group
tabl
mode
effici
viru
rescu
also
obtain
statist
differ
observ
rescu
effici
flu
ha
pcr
amplicon
plu
rg
plasmid
np
plasmid
utregfputr
without
sequenc
np
plasmid
e
plasmid
minu
np
plasmid
f
amplicon
plasmid
pictur
obtain
hpt
magnif
use
carl
zeiss
axiophot
photomicroscop
uv
filter
amplicon
amplifi
method
describ
supplement
inform
pdm
compar
ha
na
amplicon
rg
plasmid
pdm
background
use
cotransfect
ha
na
amplicon
result
approxim
fold
less
viru
pdm
supernat
transfect
cell
compar
use
ha
amplicon
alon
ha
pdm
similar
trend
observ
ca
background
use
compar
reassort
ca
ha
pdm
ca
virus
rescu
strain
use
amplicon
cotransfect
either
ca
background
effici
similar
obtain
use
ha
na
amplicon
strain
must
note
reassort
virus
carri
gene
segment
either
ca
encod
na
subtyp
may
affect
rescu
effici
pdm
ha
gene
segment
nevertheless
result
show
either
strategi
use
flu
pcr
amplicon
suitabl
method
speed
recoveri
influenza
virus
rg
sinc
pcr
strategi
signal
initi
use
want
determin
whether
amplicon
lack
signal
could
better
substrat
gener
subsequ
amplif
vrna
segment
pcr
amplicon
prepar
design
pdm
utr
pdm
utr
use
overlap
pcr
method
mention
signal
omit
similarli
pcr
amplicon
ha
na
lack
signal
prepar
use
control
use
either
viru
background
viru
rescu
possibl
ha
na
pcr
amplicon
lack
signal
although
rescu
effici
fold
lower
overlap
pcr
strategi
reconstitut
ha
na
pcr
amplicon
strategi
produc
fulllength
ha
na
pcr
amplicon
base
amplif
promot
vector
subtyp
specif
intern
primer
ha
na
depend
product
primer
contain
termin
signal
ha
pdm
amplifi
follow
overlap
fragment
fragment
span
primer
set
incorpor
signal
fragment
span
polfragrev
poli
promot
fragment
amplifi
use
polf
primer
three
pcr
product
purifi
agaros
gel
electrophoresi
combin
equal
proport
ng
creat
full
length
pdm
pcr
amplicon
use
primer
pair
b
overlap
pcr
strategi
produc
ha
segment
polybas
cleavag
site
chickennorth
sumatra
strain
remov
replac
sequenc
low
pathogen
viru
follow
strategi
describ
c
depict
strategi
use
gener
full
length
pcr
product
pdm
strain
e
altern
pcr
product
gener
serv
control
pcrbase
revers
genet
agaros
gel
show
expect
size
lane
pcr
amplicon
lane
generul
tm
kb
plu
dna
ladder
lane
pdm
lane
pdm
utr
lane
pdm
lane
pdm
utr
lane
utrha
pdm
utr
lane
utrna
pdm
utr
f
polha
lane
polna
lane
amplicon
prepar
follow
strategi
describ
depict
b
respect
lane
correspond
generul
tm
kb
plu
dna
ladder
bp
fermenta
inc
lane
pcr
product
amplifi
supplement
inform
use
amplicon
signal
passag
mdck
cell
viru
titer
reassort
ha
pdm
ha
pdm
pdm
pdm
increas
although
fold
lower
obtain
fulllength
signalcontain
amplicon
ha
pmd
ha
pdm
pdm
pdm
tabl
result
consist
previou
observ
use
flu
gfp
amplicon
lack
signal
suggest
presenc
signal
help
gener
optim
fulllength
flu
pcr
amplicon
expand
potenti
use
pcr
amplicon
suitabl
surrog
system
recov
influenza
virus
without
use
plasmid
viru
segment
amplifi
gener
full
set
flu
pcr
amplicon
encod
one
viral
segment
fig
optim
cocktail
eight
pcr
amplicon
base
ha
na
gene
pdm
amplicon
strain
consist
mg
mg
polpa
mg
polnp
mg
polha
pdm
mg
polna
pdm
mg
polm
mg
poln
mg
along
mg
np
mg
express
helper
plasmid
mixtur
transfect
cocultur
cell
ratio
densiti
cell
result
low
effici
viru
rescu
titer
tcid
hpt
detect
ha
titer
tabl
viru
blind
passag
mdck
cell
result
viru
titer
order
tcid
ml
ha
titer
studi
expand
includ
full
set
pcr
product
np
express
plasmid
replac
correspond
amplicon
reaction
includ
pcr
amplicon
plasmid
vero
mdck
cell
approv
influenza
vaccin
product
investig
whether
flu
pcr
amplicon
rescu
either
mode
possibl
cell
vero
cell
cotransfect
flu
ha
alon
combin
na
pcr
amplicon
strain
rg
plasmid
result
viru
rescu
observ
hpt
tcid
ml
fold
lower
effici
compar
whole
plasmidbas
system
tabl
blind
passag
supernat
vero
cell
hpt
mdck
cell
result
viru
titer
similar
obtain
use
whole
plasmid
rg
system
around
tcid
ml
use
approach
viru
rescu
also
possibl
mdck
cell
ha
pcr
amplicon
two
strain
aviet
tabl
case
ha
pcr
amplicon
prepar
carri
canin
promot
termin
signal
ha
gene
amplifi
use
overlap
pcr
remov
gene
polybas
cleavag
site
sequenc
fig
cotransfect
ha
pcr
amplicon
rg
plasmid
strain
mdck
cell
result
viru
rescu
titer
tcid
ml
hpt
tcid
ml
blind
passag
mdck
cell
tabl
reassort
virus
like
previou
transfect
studi
remov
signal
pcr
product
result
impair
viru
rescu
reassort
virus
remov
sequenc
result
viru
rescu
report
signific
modif
introduc
plasmidbas
revers
genet
system
influenza
base
pcr
amplicon
order
optim
maxim
amplif
gene
interest
strategi
involv
overlap
pcr
fragment
segment
design
use
conjunct
high
fidel
polymeras
correspond
buffer
phusion
highfidel
pcr
master
mix
gc
buffer
new
england
biolab
enzym
perform
best
hand
compar
seven
commerci
avail
dna
polymeras
supplementari
materi
method
synthesi
full
length
flu
pcr
amplicon
impli
produc
overlap
pcr
fragment
distinct
differ
gcversu
atrich
region
human
canin
promot
approxim
gcrich
wherea
ha
segment
approxim
atrich
data
shown
approach
succeed
produc
overlap
pcr
amplicon
ha
na
segment
differ
subtyp
includ
shown
intern
gene
segment
strain
design
overlap
primer
optim
pcr
condit
fig
amount
obtain
reaction
full
length
flu
pcr
amplicon
order
mg
fig
suffici
transfect
viru
rescu
compar
amount
plasmid
dna
use
transfect
convent
plasmidbas
rg
system
tabl
vaccin
candid
polybas
cleavag
site
rerrrkkr
highli
pathogen
strain
easili
remov
replac
low
pathogen
sequenc
tetr
virtu
adequ
set
primer
overlap
pcr
tabl
fig
fig
plaqu
assay
reveal
rescu
viru
strictli
depend
presenc
tpcktrypsin
strongli
suggest
viru
virus
recov
revers
genet
use
infect
mdck
cell
moi
hpi
cell
fix
paraformaldehyd
pb
solut
santa
cruz
viral
antigen
detect
ifa
use
subtyp
specif
monoclon
antibodi
fitclabel
antimous
antibodi
green
counterstain
perform
propidium
iodid
red
mab
specif
ha
pdm
viru
reaction
ha
strain
cell
nuclei
seen
red
react
propidium
iodid
b
c
posit
viral
antigen
green
signal
detect
use
mab
cell
infect
either
pdm
pdm
virus
respect
mab
specif
viru
reaction
cell
e
posit
reaction
mab
cell
infect
f
sequenc
ha
cleavag
site
viru
indic
presenc
low
pathogen
pattern
tetr
creat
overlap
pcr
indic
materi
method
fig
g
plaqu
assay
perform
describ
materi
method
virus
form
plaqu
agaros
plate
presenc
mgml
tpcktrypsin
absenc
prepar
devoid
wild
type
viru
contamin
fig
surpris
sinc
overlap
pcr
fragment
produc
purifi
independ
prior
assembl
reaction
gener
full
length
pcr
product
addit
low
mutat
rate
observ
approxim
plaquepurifi
virus
singl
nucleotid
mutat
fulli
understood
stage
whether
mutat
natur
present
wild
type
viru
notabl
ha
gene
clone
tabl
contain
mutat
aa
posit
shown
relat
switch
receptor
specif
link
sialic
acid
sinc
viru
use
report
undergon
one
passag
egg
possibl
homogen
popul
contribut
find
small
mutat
rate
among
clone
nevertheless
result
clearli
show
pcrbase
rg
strategi
creat
heterogen
viru
popul
regard
could
argu
pcrbase
approach
like
better
repres
viru
popul
present
origin
viru
isol
compar
plasmidbas
system
sinc
clear
whether
presenc
signal
would
either
posit
neg
effect
product
fulllength
flu
pcr
amplicon
import
determin
whether
run
transcript
would
make
differ
viru
rescu
effici
use
pcr
amplicon
result
show
presenc
signal
end
flu
pcr
amplicon
greatli
improv
viru
rescu
effici
approxim
fold
tabl
observ
consist
throughout
studi
sinc
omit
signal
result
less
effici
amplif
flu
gfp
replicon
fig
significantli
less
viru
rescu
human
canin
cell
tabl
ha
na
pcr
amplicon
contribut
produc
viru
effici
background
laboratori
adapt
strain
also
strain
like
ca
live
attenu
vaccin
strain
wild
type
strain
tabl
furthermor
approach
limit
product
viru
transfect
cocultur
cell
transfect
vero
cell
mode
also
result
viru
rescu
tabl
viru
rescu
viru
mdck
cell
attenu
ha
pcr
amplicon
carri
signal
also
success
tabl
boundari
system
extend
show
complet
set
flu
pcr
amplicon
effect
recov
rg
context
express
plasmid
encod
influenza
polymeras
complex
tabl
importantli
express
compet
pcr
version
np
also
effect
rescu
viru
transfect
reaction
contain
plasmid
tabl
studi
impli
protein
express
studi
could
perform
without
prepar
clone
although
must
emphas
systemat
studi
evalu
differ
protein
express
pcr
amplicon
correspond
plasmid
perform
although
argu
rescu
effici
lower
use
plasmidbas
approach
optim
pcrbase
system
like
possibl
manipul
amount
proport
amplicon
transfect
analysi
beyond
scope
present
report
could
also
argu
pcrbase
system
may
produc
variabl
viru
popul
one
obtain
use
plasmidbas
system
although
possibl
inher
natur
influenza
virus
evolv
point
mutat
therefor
revers
genet
system
error
free
howev
sequenc
reassort
produc
studi
show
mutat
would
alter
antigen
ha
surfac
protein
regard
vaccin
develop
long
vaccin
seed
stock
antigen
ident
vaccin
candid
mutat
would
irrelev
fact
inactiv
influenza
vaccin
prepar
classic
reassort
two
prerequisit
ha
surfac
gene
deriv
vaccin
candid
high
growth
egg
full
genom
sequenc
vaccin
virus
prerequisit
approv
vaccin
fda
overal
implic
pcrbase
approach
rg
develop
highli
signific
use
combin
pcr
amplicon
plasmid
would
possibl
streamlin
studi
gene
variant
one
gene
segment
determin
fit
pathogenesi
biolog
aspect
viru
sever
mutant
virus
mutat
one
gene
could
produc
without
prepar
individu
clone
recoveri
virus
entir
pcr
product
impli
viral
system
could
amen
similar
strategi
could
particularli
import
virus
genom
larger
influenza
viru
occasion
associ
clone
difficulti
plasmid
instabl
fact
pcr
amplif
purpos
viru
gener
alreadi
done
coronavirus
although
pcr
product
use
templat
vitro
rna
transcript
result
rna
later
transfect
cell
summari
rg
system
influenza
develop
requir
clone
step
recoveri
virus
profound
implic
vaccin
develop
pandem
prepared
studi
influenza
virus
mouseadapt
viru
virus
previous
describ
highli
pathogen
viru
strain
strain
gift
teguh
prajitno
vaksindo
indonesia
sent
us
ron
fouchier
erasmu
medic
center
netherland
viru
clade
obtain
center
diseas
control
prevent
atlanta
ga
cdc
influenza
strain
grown
revers
genet
clone
obtain
peter
pales
mount
sinai
school
medicin
new
york
ny
viru
stock
prepar
specif
pathogen
free
old
embryon
chicken
egg
follow
standard
techniqu
growth
influenza
virus
mdck
vero
cell
maintain
modifi
eagl
medium
mem
sigmaaldrich
st
loui
mo
contain
fetal
bovin
serum
fb
sigmaaldrich
human
embryon
kidney
celllin
cultur
optimem
gibco
grand
island
ny
contain
fb
rg
system
viru
gift
dr
peter
pales
mount
sinai
school
medicin
new
york
ny
rg
system
ann
arbor
cold
adapt
ca
viru
produc
homolog
strain
provid
us
ruben
doni
cdc
clone
vector
sutton
et
al
unpublish
rg
system
previous
describ
bidirect
rg
vector
contain
canin
sequenc
gift
ruben
doni
gene
segment
subclon
vector
clone
origin
prepar
vector
data
shown
plasmid
provid
ron
fouchier
encod
wt
ha
ha
gene
respect
viru
plasmid
previous
describ
plasmid
encod
influenza
egfp
report
replicon
gift
robert
webster
st
jude
children
research
hospit
memphi
tn
vrna
cdna
wild
type
blind
passag
reassort
virus
prepar
previous
describ
briefli
total
rna
extract
use
rneasi
kit
qiagen
valencia
ca
follow
manufactur
instruct
revers
transcript
carri
primer
avian
myeloblastosi
viru
amv
revers
transcriptas
promega
madison
wi
cdna
store
use
flu
egfp
replicon
amplifi
primer
use
phwegfp
plasmid
dna
templat
pcr
amplicon
pa
np
gener
primer
pcmvf
pbghr
design
respect
flu
pcr
amplicon
flank
sequenc
correspond
immediateearli
human
cytomegaloviru
cmv
promot
bovin
growth
hormon
bgh
polyadenyl
signal
pcr
condit
similar
overlap
pcr
pdm
pdm
amplicon
except
use
pg
correspond
plasmid
dna
templat
see
pcr
amplif
two
method
use
demonstr
pcr
product
devoid
spuriou
plasmid
dna
contamin
pcr
product
digest
dpn
new
england
biolab
ipswich
h
separ
purifi
agaros
gel
electrophoresi
subsequ
ng
purifi
pcr
product
use
transform
e
coli
cell
invitrogen
carlsbad
ca
altern
primer
pair
pcmvf
use
demonstr
lack
plasmid
dna
contamin
purifi
pcr
reaction
tabl
strategi
also
use
demonstr
plasmid
dna
contamin
pcr
amplif
promot
rg
vector
instanc
plasmid
dna
contamin
observ
either
method
data
shown
pcr
strategi
overlap
ha
na
gene
segment
human
promot
schemat
represent
overlap
pcr
approach
shown
fig
use
set
primer
describ
tabl
two
overlap
pcr
fragment
gener
ha
pdm
gene
first
fragment
span
primer
set
incorpor
signal
second
fragment
amplifi
primer
pair
polfragrev
human
promot
pcr
amplifi
use
primer
polf
plasmid
vector
templat
detail
amplif
condit
pcr
fragment
provid
supplementari
inform
fig
b
pcr
product
purifi
agaros
gel
electrophoresi
combin
equal
proport
gener
fulllength
ha
pcr
amplicon
use
primer
pair
ml
pcr
reaction
mixtur
contain
ng
pcr
product
ml
master
pcr
mix
ml
dmso
pmolml
primer
pcr
reaction
condit
sec
cycl
min
min
end
min
pcr
product
amplifi
use
phusion
highfidel
pcr
master
mix
gc
buffer
new
england
biolab
ipswich
altern
ha
pcr
product
without
signal
sequenc
lack
element
gener
serv
control
pcrbase
revers
genet
fig
tabl
pcr
product
purifi
agaros
gel
electrophoresi
quantit
gel
purif
use
nanodrop
nanodrop
wilmington
de
overlap
pcr
product
produc
na
pdm
gene
use
primer
pair
ptifragfwd
polfragrev
wherea
full
length
na
pcr
amplicon
gener
primer
pair
altern
fulllength
na
amplicon
gener
use
specif
primer
note
tabl
similar
strategi
use
amplifi
pcr
product
polybas
cleavag
site
sequenc
remov
use
overlap
pcr
product
span
sequenc
primer
pair
ptifragfwd
polfragrev
wherea
full
length
ha
pcr
amplicon
gener
primer
set
full
length
na
gene
segment
strain
amplifi
without
gener
intern
overlap
fragment
use
primer
set
rather
subsequ
introduc
pcr
reaction
gener
fulllength
pcr
amplicon
carri
promot
tabl
compar
rescu
effici
pcr
amplicon
plasmid
also
use
control
set
revers
genet
system
use
full
set
pcr
amplicon
pdm
surfac
gene
segment
viru
intern
gene
segment
select
intern
gene
amplifi
total
cdna
prepar
wildtyp
strain
initi
titer
tcid
ml
mdck
cell
overlap
pcr
amplicon
signal
sequenc
ptifragfwd
primer
use
produc
n
termin
fragment
polfragrev
primer
use
produc
c
termin
fragment
fragment
mix
ng
overlap
pcr
reaction
perform
use
primer
pcr
paramet
similar
pdm
pdm
amplicon
describ
final
product
label
similar
strategi
follow
gene
segment
fuse
signal
sequenc
use
primer
pair
primer
respect
final
pcr
amplicon
design
respect
addit
detail
provid
supplementari
inform
fig
overlap
pcr
canin
promot
gener
ha
pcr
amplicon
contain
promot
perform
follow
promot
amplifi
vector
use
primer
pair
condit
initi
denatur
sec
cycl
sec
sec
min
final
extens
min
tabl
overlap
ha
fragment
one
contain
signal
produc
primer
pair
second
one
primer
pair
kpolutrr
follow
condit
prepcr
treatment
sec
cycl
sec
sec
min
final
extens
min
tabl
amount
overlap
ha
pcr
product
amplicon
calcul
mix
togeth
concentr
ng
full
length
ha
pcr
amplicon
gener
primer
pair
thermal
profil
denatur
sec
cycl
sec
min
min
extens
min
pcr
product
amplifi
use
phusion
highfidel
pcr
master
mix
gc
buffer
partial
plasmidfre
rescu
plasmid
choic
replac
correspond
flu
pcr
amplicon
viru
rescu
perform
essenti
describ
minor
modif
briefli
cocultur
cell
ratio
cell
per
well
seed
well
tissu
cultur
plate
plate
incub
overnight
follow
day
mg
plasmid
flu
pcr
amplicon
incub
min
ml
transfect
reagent
miru
bio
llc
madison
wi
transfect
allow
occur
overnight
media
replac
fresh
serumfre
optimem
h
posttransfect
hpt
l
ethyl
chloromethyl
keton
tpck
treat
trypsin
mgml
ad
cell
supernat
mdck
vero
cell
grown
confluenc
flask
trypsin
trypsinedta
invitrogen
resuspend
optimem
contain
fb
cell
suspens
seed
tissu
cultur
plate
incub
overnight
transfect
transfect
posttransfect
step
proceed
describ
mdck
cocultur
cell
except
vero
cell
incub
mgml
tpcktrypsin
supernat
transfect
cell
collect
time
indic
tabl
blind
passag
either
mdck
cell
old
embryon
chicken
egg
monitor
presenc
rescu
virus
tcid
titer
determin
mdck
cell
reed
muench
method
describ
viru
stock
prepar
frozen
use
rescu
virus
examin
plaqu
assay
mdck
cell
briefli
confluent
cell
monolay
plate
infect
dilut
viru
total
volum
ml
pb
h
cell
wash
twice
pb
cover
overlay
modifi
eagl
medium
contain
agar
bsa
glutamin
note
ugml
tpck
treatedtrypsin
plate
incub
co
day
incub
overlay
remov
cell
stain
crystal
violet
sequenc
ha
gene
plaquepurifi
virus
agaros
pluck
area
plate
plaqu
observ
virus
elut
agaros
pluck
tissu
cultur
media
later
expand
mdck
cell
h
prior
rna
extract
cdna
synthesi
pcr
sequenc
antisera
viru
rais
chicken
infect
live
attenu
version
viru
background
viru
similar
previous
describ
collect
sera
treat
receptordestroy
enzym
accur
chemic
scientif
corp
westburi
ny
prior
hi
assay
describ
anim
influenza
train
manual
whocdscsr
nc
sequenc
overlap
pcr
product
viral
cdna
ha
sequenc
purifi
clone
rescu
reassort
perform
use
combin
univers
primer
custom
made
primer
avail
upon
request
big
dye
termin
cycl
sequenc
kit
appli
biosystem
foster
citi
ca
genet
analyz
appli
biosystem
foster
citi
ca
accord
manufactur
instruct
sequenc
analysi
perform
use
softwar
avail
lasergen
packag
dnastar
inc
madison
wi
cell
grown
plate
infect
rescu
influenza
virus
dose
tcid
well
hpi
cell
wash
precool
phosphat
buffer
salin
pb
buffer
fix
neutral
formaldehyd
min
room
temperatur
cell
incub
block
solut
normal
goat
serum
pb
h
probe
primari
antibodi
min
two
monoclon
antibodi
use
identifi
recombin
influenza
virus
mab
specif
ha
protein
virus
react
ha
subtyp
influenza
virus
mab
specif
ha
subtyp
influenza
virus
antibodyantigen
complex
incub
fluorescein
isothiocyan
fitc
conjug
goat
antimous
ig
hl
southernwest
biotech
associ
inc
birmingham
al
min
room
temperatur
cell
wash
three
time
pb
incub
counterstain
propidium
iodid
pi
examin
axiophot
photomicroscop
produc
carl
zeiss
lex
nm
lem
nm
ms
materi
method
enzym
kit
use
gener
fulllength
flu
pcr
amplicon
figur
gener
ha
na
amplicon
cdna
virus
prepar
describ
main
text
generul
tm
kb
plu
dna
ladder
lane
unspecif
pcr
product
obtain
use
onestep
rtpcr
gener
full
length
ha
pdm
gene
bp
primer
polhr
lane
n
terminu
ha
pdm
specif
pcr
product
bp
obtain
use
primer
pair
incorpor
signal
lane
c
terminu
overlap
ha
pdm
specif
pcr
product
bp
use
primer
pair
polfragrev
lane
n
terminu
na
pdm
specif
pcr
product
bp
obtain
use
primer
pair
ptifragfwd
lane
c
terminu
na
pdm
specif
pcr
product
bp
polfragrev
primer
set
lane
first
specif
pcr
fragment
bp
obtain
primer
ptifragfwd
lane
second
ha
specif
pcr
fragment
bp
obtain
primer
pair
lane
fulllength
na
amplicon
bp
gener
primer
set
ml
pcr
reaction
mixtur
contain
ng
cdna
ml
master
pcr
mix
ml
dmso
pmolml
primer
pcr
reaction
condit
sec
cycl
sec
min
end
min
pcr
product
amplifi
use
phusion
highfidel
pcr
master
mix
gc
buffer
bp
primer
pair
polfragrev
pcr
condit
similar
describ
sfig
b
fulllength
pcr
amplicon
overlap
pcr
product
gener
mix
concentr
ng
product
amplifi
forward
primer
revers
primer
describ
main
text
thermal
profil
denatur
sec
cycl
sec
min
min
extens
min
pcr
product
amplifi
use
phusion
highfidel
pcr
master
mix
gc
buffer
final
overlap
pcr
amplicon
design
figur
ha
pcr
amplicon
flank
promot
two
produc
overlap
pcr
product
ha
ha
gene
segment
pcr
condit
use
similar
describ
sfig
main
text
lane
promot
bp
amplifi
vector
use
primer
pair
lane
pcr
fragment
contain
nterminu
ha
signal
bp
produc
primer
pair
size
bp
lane
pcr
fragment
contain
cterminu
ha
bp
produc
primer
pair
kpolutrr
lane
pcr
fragment
contain
nterminu
ha
bp
amplifi
lane
lane
pcr
fragment
contain
cterminu
ha
bp
produc
lane
lane
two
overlap
ha
pcr
product
pcr
fragment
mix
concentr
ng
product
gener
full
length
pcr
amplicon
bp
use
primer
pair
lane
two
overlap
ha
pcr
product
pcr
fragment
mix
concentr
ng
amplifi
gener
full
length
amplicon
bp
use
primer
pair
lane
lane
except
utr
bp
lack
signal
amplif
primer
pair
lane
lane
except
utr
bp
lack
signal
amplif
generul
tm
kb
plu
dna
ladder
jpg
